Back to search

Article

Biomedical application of TiO2NPs can cause arterial thrombotic risks through triggering procoagulant activity, activation and aggregation of platelets

2024-04-03

Abstract excerpt

<title>Abstract</title> <p>Background Titanium dioxide nanoparticles (TiO<sub>2</sub>NPs) are widely used in medical application. However, the relevant health risk has not been completely assessed, the potential of inducing arterial thrombosis (AT) in particular. Methods Alterations in platelet function and susceptibility to arterial thrombosis induced by TiO<sub>2</sub>NPs were examined using peripheral blood...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
23bf3545-e178-58f5-a4f8-7199d9c530d8
DOI
10.21203/rs.3.rs-4187973/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Biomedical application of TiO2NPs can cause arterial thrombotic risks through triggering procoagulant activity, activation and aggregation of plateletsDOI 10.21203/rs.3.rs-4187973/v1
Select a neighboring publication to make it the new centre.